These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9709930)

  • 1. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
    Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
    Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer.
    Salvatori M; Rufini V; Reale F; Samanes Gajate AM; Maussier ML; Revelli L; Troncone L; Ardito G
    World J Surg; 2003 Jul; 27(7):770-5. PubMed ID: 14509503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
    Cailleux AF; Baudin E; Travagli JP; Ricard M; Schlumberger M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radio-guided surgery for non-131I-avid thyroid cancer.
    Rubello D; Pelizzo MR; Casara D; Piotto A; Toniato A; Fig L; Gross M
    Thyroid; 2006 Nov; 16(11):1105-11. PubMed ID: 17123337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of patients to detect recurrent thyroid carcinoma.
    Grigsby PW; Baglan K; Siegel BA
    Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
    Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
    J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature.
    Negele T; Meisetschläger G; Brückner T; Scheidhauer K; Schwaiger M; Vogelsang H
    Langenbecks Arch Surg; 2006 Jun; 391(3):178-86. PubMed ID: 16491404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraoperative localization measurement following preoperative radioiodine marking to facilitate the treatment of differentiated thyroid carcinoma].
    Littmann K; Magdsick G; Strötges MW; Eigler FW
    Chirurg; 1980 Jun; 51(6):389-94. PubMed ID: 7449540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
    Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
    J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completion thyroidectomy of well-differentiated thyroid cancer - a prospective, randomised study.
    Proczko M; Stefaniak T; Sworczak K; Kobiela J; Lachiński AJ; Stepaniak P; Sledziński Z
    Endokrynol Pol; 2013; 64(5):335-9. PubMed ID: 24186588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcome in cervical recurrences of papillary or follicular thyroid cancer].
    Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J
    Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.